• Users Online: 1468
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2018  |  Volume : 30  |  Issue : 3  |  Page : 103-109

Role of interleukin 6 and highly sensitive C-reactive protein in diabetic nephropathy


Internal Medicine Department, Zagazig University, Zagazig, Egypt

Correspondence Address:
Dr. Ayman M.E.M Sadek
Shoubak Basta, Zagazig, Shakia, 44519
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ejim.ejim_27_18

Rights and Permissions

Context The pathogenesis of diabetic nephropathy (DN) is still incompletely understood. Few studies have linked the cellular inflammatory markers, interleukin 6 (IL-6) and highly sensitive C-reactive protein (hs-CRP), to the development of DN. Aim We aimed to explore the link among IL-6, hs-CRP, and grades of DN in both types of diabetes mellitus (DM). Settings and design We carried out a case–control study on participants selected from the outpatient clinic of Internal Medicine Department. Patients and methods We worked on 91 participants, comprising 78 patients and 13 controls. The patient group was further subdivided into two subgroups: subgroup I [39 patients type 1 DM (T1DM)] and subgroup II [39 patients type 2 DM (T2DM)]. Each subgroup was categorized according to the urinary albumin excretion rate into three divisions: A (<20 μg/min), B (20–200 μg/min), and C (>200 μg/min). We applied history taking, clinical examination, routine investigation, and IL-6 with hs-CRP testing to all participants. Statistical analysis We used Shapiro–Wilk test, χ2 test, Student’s t test, one-way analysis of variance, Kruskal–Wallis test, least significant difference test, and Pearson’s correlation coefficient for data analysis. Results Despite the significant difference of laboratory data between patient and control groups, least significant difference analysis revealed a nonsignificant difference between patients with T1DM and those with T2DM. On the level of the in-groups analysis, the most significant key players were hs-CRP and IL-6 among the three urinary albumin excretion rate categories of patients with T1DM and T2DM, with P values less than 0.01. Conclusions We concluded that IL-6 and hs-CRP might be used as sensitive markers for the development of DN.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2048    
    Printed171    
    Emailed0    
    PDF Downloaded289    
    Comments [Add]    
    Cited by others 1    

Recommend this journal